KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Steris (STE) EBIT (2018 - 2025)

Steris has reported EBIT over the past 8 years, most recently at $273.2 million for Q4 2025.

  • For Q4 2025, EBIT rose 11.37% year-over-year to $273.2 million; the TTM value through Dec 2025 reached $1.0 billion, up 14.96%, while the annual FY2025 figure was $866.6 million, 3.65% up from the prior year.
  • EBIT for Q4 2025 was $273.2 million at Steris, up from $265.8 million in the prior quarter.
  • Over five years, EBIT peaked at $748.3 million in Q1 2023 and troughed at -$306.4 million in Q3 2022.
  • A 5-year average of $187.8 million and a median of $200.3 million in 2021 define the central range for EBIT.
  • On a YoY basis, EBIT climbed as much as 68697.62% in 2022 and fell as far as 363.01% in 2022.
  • Year by year, EBIT stood at $202.9 million in 2021, then dropped by 5.98% to $190.8 million in 2022, then increased by 18.69% to $226.5 million in 2023, then grew by 8.31% to $245.3 million in 2024, then increased by 11.37% to $273.2 million in 2025.
  • Business Quant data shows EBIT for STE at $273.2 million in Q4 2025, $265.8 million in Q3 2025, and $246.0 million in Q2 2025.